OpenCitations
Works that cite this article, indexed by OpenCitations.
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis
International Immunology 27(1) (2014)
Nicholas Schwab; Tilman Schneider-Hohendorf; Heinz Wiendl
Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation
Archives of Medical Science 5 (2016)
Maciej Nowacki; Łukasz Nazarewski; Tomasz Kloskowski; Dominik Tyloch; Marta Pokrywczyńska; Katarzyna Pietkun; Arkadiusz Jundziłł; Janusz Tyloch; Samy L. Habib; Tomasz Drewa
Induction of PD-L1 on monocytes: A new mechanism by which IVIg inhibits mixed lymphocyte reactions
Immunobiology 219(9) (2014)
Lauriane Padet; Lionel Loubaki; Renée Bazin
Peptides, Antibodies, Peptide Antibodies and More
International Journal of Molecular Sciences 20(24) (2019)
Nicole Trier; Paul Hansen; Gunnar Houen
Efficacy of Anti-Interleukin-2 Receptor Antibody in Reducing the Incidence of Acute Rejection After Renal Transplantation
Nephro-Urology Monthly 4(4) (2012)
Alexandre Braga Liborio; Tacyano Tavares Leite
Efficacy of plasmapheresis on donor‐specific antibody reduction by HLA specificity in post–kidney transplant recipients
Transfusion 55(4) (2014)
Chisa Yamada; Daniel S. Ramon; Marilia Cascalho; Randall S. Sung; Alan B. Leichtman; Milagros Samaniego; Robertson D. Davenport
Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates
Expert Review of Clinical Immunology 11(1) (2014)
Divyanshu Dubey; Bernd C Kieseier; Hans Peter Hartung; Bernhard Hemmer; William A Miller-Little; Olaf Stuve